Rate Cuts Likely Won’t Happen Next Year: Julian Emanuel
- Pimco’s Schneider Sees Slight, Prolonged Recession Ahead
- Are Chinese Big Tech Stocks Ripe for a Rebound?
Stories You May Also Like:
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here’s Why That’s a Smart Move.
Hot off the approval of its gene therapy for a pair of rare hereditary blood disorders, Vertex Pharmaceuticals (VRTX -0.96%)
